The Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels
- Citation:
- ALFIKI, M. M., H. S. El-Abhar, D. M. Abdallah, and L. I. N. A. E. KHEDR, "The Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels", Med. J. Cairo Univ. , vol. 90, pp. 65-72, 2022.